Shareholder Information

Proteomics International Laboratories Ltd is listed on the Australian Securities Exchange (ASX).

Proteomics International Laboratories Ltd shares can be traded on ASX. For the current share price, please refer to the ASX website (ASX code: PIQ).

 

Share Registry

Proteomics International Laboratories Ltd’s share register is maintained by Automic.

Security holders can view their holdings, obtain statements and maintain their personal information via the online portal provided by Automic: https://investor.automic.com.au/#/home. You will need your Security Reference Number (SRN) or Holder Identification Number (HIN) – displayed on Issuer Sponsored/CHESS holding statements.

Alternatively, security holders can contact Automic directly using the contact details provided below.

Automic

Postal address: GPO Box 5193, Sydney NSW 2000

Telephone: 1300 288 664 (within Australia)

Telephone: +61 2 9698 5414 (outside Australia)

Email: hello@automic.com.au

 

Shareholder Communications

Receiving your shareholder communications electronically is the best way to stay informed and will help to minimise paper usage. If you have not already, we encourage you to make the switch to paperless communications and provide us with your email address.

You can make a standing election to receive some or all of your shareholder communications in physical or electronic form.

Of course, you will always be able to access and read our Annual Report, Notice of Meeting and other shareholder documents when they are published on our website and the ASX platform.

To review or update your preference, simply log on to the registry portal https://investor.automic.com.au/#/home and update your ‘Communication Preferences’ under ‘My Details’.

 

Corporate Information

Issuer Code: PIQ

Official Listing Date: 16 April 2015

GICS Industry Group: Pharmaceuticals, Biotechnology & Life Sciences

Mailing address: Box 3008, Broadway, Nedlands, WA 6009, Australia

Head Office Telephone: +61 8 9389 1992

Email address: enquiries@proteomicsinternational.com

Subscribe
  • This field is for validation purposes and should be left unchanged.